Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 6/20 | 0.37 |
| ▸ | ADORA2B | P29275 | 5/20 | 0.37 |
| ▸ | PDE4A | P27815 | 5/20 | 0.37 |
| ▸ | PDE4B | Q07343 | 5/20 | 0.37 |
| ▸ | PDE4C | Q08493 | 5/20 | 0.37 |
| ▸ | PDE4D | Q08499 | 5/20 | 0.37 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.37 |
| ▸ | ALPL | P05186 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | PNP | P00491 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29026230 | 0.81 | PNP (0.36) | PNPALDH1A1PARP1 | |
| SCHEMBL25230732 | 0.80 | PNP (0.39) | LMNAMAPTPNPALDH1A1KDM4E | |
| SCHEMBL28633084 | 0.79 | PNP (0.35) | PNPPARP1 | |
| SCHEMBL16494562 | 0.79 | PNP (0.35) | PNPPARP1 | |
| SCHEMBL6035387 | 0.79 | ADORA2A (0.42) | ADORA2AADORA2BPDE4APDE4BPDE4C | |
| SCHEMBL29202430 | 0.77 | PNP (0.34) | PNPPARP1 | |
| SCHEMBL29203681 | 0.76 | PNP (0.35) | ADORA2AADORA2BPNPPARP1 | |
| SCHEMBL29015261 | 0.75 | ADORA2A (0.46) | ADORA2AADORA2BPDE4APDE4BPDE4C | |
| SCHEMBL13731906 | 0.74 | HPRT1 (0.35) | PNPPARP1 | |
| SCHEMBL48434 | 0.74 | ATAD2 (0.54) | ATAD2ADORA2AADORA2BPDE4APDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 400 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260098287-A1 | METHOD AND KIT FOR REGENERATING REUSABLE INITIATORS FOR NUCLEIC ACID SYNTHESIS | CHENG-YAO CHEN (TW) | 2026-04-09 | — | — | US | claimed |
| EP-4569132-A2 | METHOD, KIT AND SYSTEM FOR END LABELING OF NUCLEIC ACIDS | Chen, Cheng-Yao (TW) | 2025-06-18 | — | — | EP | claimed |
| CN-119948172-A | Methods, kits and systems for nucleic acid end labeling | 陈呈尧 | 2025-05-06 | — | — | CN | claimed |
| US-20250019744-A1 | METHOD, KIT AND SYSTEM FOR END LABELING OF NUCLEIC ACIDS | Chen, Cheng-Yao (TW) | 2025-01-16 | — | — | US | claimed |
| US-20240385183-A1 | METABOLIC AND MICROBIAL BIOMARKERS FOR DETECTION OF PANCREATICOBILIARY CANCERS | NORTHWESTERN UNIVERSITY | 2024-11-21 | — | — | US | claimed |
| WO-2024059788-A2 | METHOD, KIT AND SYSTEM FOR END LABELING OF NUCLEIC ACIDS | Chen cheng yao | 2024-03-21 | — | — | WO | claimed |
| US-20240076707-A1 | METHOD FOR MODIFYING DNA BY UTILIZING GLYCOSYLASE AND OXYAMINE COMPOUND | NANJING UNIVERSITY (CN) | 2024-03-07 | — | — | US | claimed |
| CN-117321218-A | Regeneration method and kit of reusable initiators for nucleic acid synthesis | 陈呈尧 | 2023-12-29 | — | — | CN | claimed |
| EP-4282871-A1 | METHOD FOR MODIFYING DNA WITH GLYCOSIDASE AND OXYLAMINE COMPOUND | Nanjing University (CN) | 2023-11-29 | — | — | EP | claimed |
| CN-115367745-B | Tungsten-containing substance hybridization and nitrogen-doped porous carbon material and preparation method thereof | 北京化工大学 | 2023-11-24 | — | — | CN | claimed |
| EP-1419247-B1 | METHOD FOR THE PRODUCTION OF NUCLEIC ACIDS CONSISTING OF STOCHASTICALLY COMBINED PARTS OF SOURCE NUCLEIC ACIDS | DIREVO BIOTECH AG (DE) | 2006-09-20 | — | — | EP | claimed |
| EP-1430145-A4 | METHODS AND KITS FOR DETERMING A RISK TO DEVELOP CANCER, FOR EVALUATING AN EFFECTIVENESS AND DOSAGE OF CANCER THERAPY AND FOR CORRELATING BETWEEN AN ACTIVITY OF A DNA REPAIR ENZYME AND A CANCER | YEDA RES & DEV (IL) | 2006-08-16 | — | — | EP | claimed |
| US-20050130142-A1 | Method for the production of nucleic acids consisting of stochastically combined parts of source nucleic acids | DIREVO BIOTECH AG (DE) | 2005-06-16 | — | — | US | claimed |
| EP-1430145-A2 | METHODS AND KITS FOR DETERMING A RISK TO DEVELOP CANCER, FOR EVALUATING AN EFFECTIVENESS AND DOSAGE OF CANCER THERAPY AND FOR CORRELATING BETWEEN AN ACTIVITY OF A DNA REPAIR ENZYME AND A CANCER | YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD. (IL) | 2004-06-23 | — | — | EP | claimed |
| US-20040096863-A1 | Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a dna repair enzyme and a cancer | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2004-05-20 | — | — | US | claimed |
| EP-1419247-A2 | METHOD FOR THE PRODUCTION OF NUCLEIC ACIDS CONSISTING OF STOCHASTICALLY COMBINED PARTS OF SOURCE NUCLEIC ACIDS | Direvo Biotech AG (DE) | 2004-05-19 | — | — | EP | claimed |
| WO-2003012100-A2 | METHOD FOR THE PRODUCTION OF NUCLEIC ACIDS CONSISTING OF STOCHASTICALLY COMBINED PARTS OF SOURCE NUCLEIC ACIDS | DIREVO BIOTECH AG (DE) | 2003-02-13 | — | — | WO | claimed |
| EP-1281757-A1 | Method for the production of nucleic acids consisting of stochastically combined parts of source nucleic acids | Direvo Biotech AG (DE) | 2003-02-05 | — | — | EP | claimed |
| US-20030003454-A1 | Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer | YEDA RESEARCH AND DEVELOPMENT CO. LTD. AT THE WEIZMANN INSTITUTE OF SCIENCE | 2003-01-02 | — | — | US | claimed |
| WO-2002076280-A2 | METHODS AND KITS FOR DETERMING A RISK TO DEVELOP CANCER, FOR EVALUATING AN EFFECTIVENESS AND DOSAGE OF CANCER THERAPY AND FOR CORRELATING BETWEEN AN ACTIVITY OF A DNA REPAIR ENZYME AND A CANCER | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2002-10-03 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098287-A1 | METHOD AND KIT FOR REGENERATING REUSABLE INITIATORS FOR NUCLEIC ACID SYNTHESIS | DNMT3L, ADAR, UNG | ATAD2 352/4885ADORA2A 2649/4885ADORA2B 2037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.